Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delta Med is a leading medical technology company based in Italy, specializing in the development, manufacturing, and distribution of advanced vascular access solutions. The company offers a comprehensive portfolio of products, including peripheral venous catheters, safety devices, midline catheters, and specialized accessories for infusion therapy and oncology. Delta Med is recognized for its focus on innovation and patient safety, particularly in the prevention of needle-stick injuries through proprietary safety-engineered designs. In 2023, the company was acquired by the Swedish industrial group Indutrade, supporting its continued expansion and technological development in the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DeltaMed.